Home/Filings/4/0001209191-23-034445
4//SEC Filing

Williams Richard Thomas 4

Accession 0001209191-23-034445

CIK 0001797768other

Filed

Jun 4, 8:00 PM ET

Accepted

Jun 5, 5:01 PM ET

Size

5.4 KB

Accession

0001209191-23-034445

Insider Transaction Report

Form 4
Period: 2023-06-01
Williams Richard Thomas
Chief Medical Officer
Transactions
  • Tax Payment

    Common Stock

    2023-06-01$4.30/sh541$2,32669,228 total
Footnotes (3)
  • [F1]The shares were forfeited to cover a tax obligation resulting form the quarterly vesting of RSU's granted to the Reporting Person by the Issuer.
  • [F2]Includes 20,313 shares represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of the Issuer. A portion of the RSUs vest each quarter, subject to the Reporting Person's continued service as of each vesting date.
  • [F3]Includes 2,474 shares acquired under the Issuers Employee Stock Purchase Plan in May 2023.

Issuer

Kinnate Biopharma Inc.

CIK 0001797768

Entity typeother

Related Parties

1
  • filerCIK 0001825148

Filing Metadata

Form type
4
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 5:01 PM ET
Size
5.4 KB